GIFLF:OTCMKTS
Grifols SA Class A
11,13 $
0,00%
(0,00) 1D
15. sep., 15:11:14 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za GIFLF …
Tržna kapitalizacija
6,58 mrd.
Povprečni promet
543,00
Promet
0,00
52-tedenski najvišji tečaj
12,90 $
52-tedenski najnižji tečaj
10,13 $
Beta
0,90
Št. izdanih delnic
426,13 mio.
Št. zaposlenih
25 tis.
Tržna kapitalizacija
6,58 mrd.
Povprečni promet
543,00
Promet
0,00
52-tedenski najvišji tečaj
12,90 $
52-tedenski najnižji tečaj
10,13 $
Beta
0,90
Št. izdanih delnic
426,13 mio.
Št. zaposlenih
25 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
AD HOC NEWS
·
pred 10 urami
Grifols stock gains as H1 profit rises 28.7 percent
AD HOC NEWS
·
pred 10 urami
Grifols stock after-hours at EUR 9.65: plus 1.37 percent versus prior close
The New York Times
·
pred 1 mesecem
After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Vizitka: Grifols SA Class A
Generalni direktorNacho Abia
Št. zaposlenih25 tis.
Ustanovljeno18. nov. 1940
Sedež-
Sektor-
Spletno mestogrifols.com